Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Grant revenue	$ 50,000		$ 76,165
Operating expenses:
Research and development	6,339,993	2,823,669	14,380,415	7,626,982
General and administrative	2,387,585	2,254,912	7,386,007	5,147,639
Total operating expenses	8,727,578	5,078,581	21,766,422	12,774,621
Loss from operations	(8,677,578)	(5,078,581)	(21,690,257)	(12,774,621)
Other income:
Other income (expense)	(13,129)		659,695
Interest income	12,051	20,546	41,619	102,809
Total other income (expense)	(1,078)	20,546	701,314	102,809
Net loss	$ (8,678,656)	$ (5,058,035)	$ (20,988,943)	$ (12,671,812)
Net loss per share, basic and diluted (in Dollars per share)	$ (0.34)	$ (0.24)	$ (0.85)	$ (0.61)
Weighted average common shares outstanding, basic and diluted (in Shares)	25,371,781	20,867,526	24,635,350	20,810,004
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Net loss	$ (8,678,656)	$ (5,058,035)	$ (20,988,943)	$ (12,671,812)
Other comprehensive loss:
Foreign currency translation adjustments	(53,498)	(28,172)	(118,790)	(67,663)
Comprehensive loss	$ (8,732,154)	$ (5,086,207)	$ (21,107,733)	$ (12,739,475)